Gene · 1
Papers2,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Proteomic Overview. | Proteomes | 2022 | 36412636 | PubTator, text mining | PubMed |
| Association of polymorphisms in the IL-10 promoter region with Crohn's disease. | J Clin Lab Anal | 2022 | 36408729 | PubTator, text mining | PubMed |
| Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis. | Front Oncol | 2022 | 36408192 | PubTator, text mining | PubMed |
| Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2. | Front Cell Dev Biol | 2022 | 36407105 | PubTator, text mining | PubMed |
| α-Ketoglutaramate-A key metabolite contributing to glutamine addiction in cancer cells. | Front Med (Lausanne) | 2022 | 36404951 | PubTator, text mining | PubMed |
| Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data. | Lancet Glob Health | 2022 | 36400083 | PubTator, text mining | PubMed |
| Continuous Positive Airway Pressure (CPAP)-Can this be a boon to tide over ICU crisis in pandemic? A case series. | J Family Med Prim Care | 2022 | 36387657 | PubTator, text mining | PubMed |
| Molecular basis of the PIP2-dependent regulation of CaV2.2 channel and its modulation by CaV β subunits. | Elife | 2022 | 36374183 | PubTator, text mining | PubMed |
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial. | BMJ Open | 2022 | 36368749 | PubTator, text mining | PubMed |
| Enhancing Anti-G Antibody Induction by a Live Single-Cycle Prefusion F-Expressing RSV Vaccine Improves In Vitro and In Vivo Efficacy. | Viruses | 2022 | 36366572 | PubTator, text mining | PubMed |
| Energy Dissipation Rate and Micromixing in a Two-Step Micro-Reactor with Intensively Swirled Flows. | Micromachines (Basel) | 2022 | 36363880 | PubTator, text mining | PubMed |
| Light Microscopy and Proteomic Patterns of Ovulation in Cervical Mucus. | Life (Basel) | 2022 | 36362970 | PubTator, text mining | PubMed |
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm. | Int J Mol Sci | 2022 | 36361712 | PubTator, text mining | PubMed |
| Urinary Protein Profiling for Potential Biomarkers of Chronic Kidney Disease: A Pilot Study. | Diagnostics (Basel) | 2022 | 36359427 | PubTator, text mining | PubMed |
| Structural Basis of Sequential and Concerted Cooperativity. | Biomolecules | 2022 | 36359000 | PubTator, text mining | PubMed |
| Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. | Clin Proteomics | 2022 | 36348270 | PubTator, text mining | PubMed |
| A novel classification of HCC basing on fatty-acid-associated lncRNA. | Sci Rep | 2022 | 36344648 | PubTator, text mining | PubMed |
| Best practices for multi-ancestry, meta-analytic transcriptome-wide association studies: Lessons from the Global Biobank Meta-analysis Initiative. | Cell Genom | 2022 | 36341024 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| MicroRNA-383: A tumor suppressor miRNA in human cancer. | Front Cell Dev Biol | 2022 | 36313570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1/papers?page=17